Iranian Red Crescent Medical Journal

Published by: Kowsar

Adherence to Osteoporosis Screening and Its Related Factors: A Population-Based Study, Kerman, Iran

Mohammad Jafari Sirizi 1 , Mohammad Reza Shakibi 2 , Mehdi Shafie 2 , Seddighe Mohammad-Taghizadeh 1 , Mohsen Barouni 2 and Nouzar Nakhaee 3 , *
Authors Information
1 Health Insurance Organization, Kerman Office, Kerman, IR Iran
2 Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, IR Iran
3 Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: December 2018, 20 (S1); e61473
  • Published Online: May 5, 2018
  • Article Type: Research Article
  • Received: September 7, 2017
  • Revised: October 23, 2017
  • Accepted: December 20, 2017
  • DOI: 10.5812/ircmj.61473

To Cite: Jafari Sirizi M, Shakibi M R, Shafie M, Mohammad-Taghizadeh S, Barouni M, et al. Adherence to Osteoporosis Screening and Its Related Factors: A Population-Based Study, Kerman, Iran, Iran Red Crescent Med J. 2018 ; 20(S1):e61473. doi: 10.5812/ircmj.61473.

Copyright © 2018, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Parsons LC. Osteoporosis: incidence, prevention, and treatment of the silent killer. Nurs Clin North Am. 2005;40(1):119-33. doi: 10.1016/j.cnur.2004.09.001. [PubMed: 15733951].
  • 2. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton L3, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467-75. doi: 10.1016/j.bone.2007.11.001. [PubMed: 18180210].
  • 3. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2 Suppl):S3-11. doi: 10.1016/j.ajog.2005.08.047. [PubMed: 16448873].
  • 4. Cummings SR, Melton LJ. Cummings SR, Melton LJ 3rd. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-7. Lancet. 2002;359:1761-7.
  • 5. Briggs AM, Cross MJ, Hoy DG, Sanchez-Riera L, Blyth FM, Woolf AD, et al. Musculoskeletal Health Conditions Represent a Global Threat to Healthy Aging: A Report for the 2015 World Health Organization World Report on Ageing and Health. Gerontologist. 2016;56 Suppl 2:S243-55. doi: 10.1093/geront/gnw002. [PubMed: 26994264].
  • 6. Irani AD, Poorolajal J, Khalilian A, Esmailnasab N, Cheraghi Z. Prevalence of osteoporosis in Iran: A meta-analysis. J Res Med Sci. 2013;18(9):759-66. [PubMed: 24381618].
  • 7. Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23(9):2239-56. doi: 10.1007/s00198-012-1964-3. [PubMed: 22419370].
  • 8. Larijani B, Hossein-Nezhad A, Mojtahedi A, Pajouhi M, Bastanhagh MH, Soltani A, et al. Normative data of bone Mineral Density in healthy population of Tehran, Iran: a cross sectional study. BMC Musculoskelet Disord. 2005;6:38. doi: 10.1186/1471-2474-6-38. [PubMed: 15992408].
  • 9. Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, et al. Longitudinal trends in use of bone mass measurement among older americans, 1999-2005. J Bone Miner Res. 2008;23(7):1061-7. doi: 10.1359/jbmr.080232. [PubMed: 18302495].
  • 10. Oden A, McCloskey EV, Johansson H, Kanis JA. Assessing the impact of osteoporosis on the burden of hip fractures. Calcif Tissue Int. 2013;92(1):42-9. doi: 10.1007/s00223-012-9666-6. [PubMed: 23135744].
  • 11. Lochmuller EM, Muller R, Kuhn V, Lill CA, Eckstein F. Can novel clinical densitometric techniques replace or improve DXA in predicting bone strength in osteoporosis at the hip and other skeletal sites? J Bone Miner Res. 2003;18(5):906-12. doi: 10.1359/jbmr.2003.18.5.906. [PubMed: 12733731].
  • 12. Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening, and treatment: a review. J Womens Health (Larchmt). 2014;23(7):563-72. doi: 10.1089/jwh.2013.4611. [PubMed: 24766381].
  • 13. Kern LM, Powe NR, Levine MA. Association between screening for osteoporosis and the incidence of hip fracture. Ann Intern Med. 2005;142:173–81.
  • 14. World Health Organization. Cancer Control: Knowledge Into Action: WHO Guide for Effective Programmes: Module 4: Diagnosis and Treatment. WHO Guidelines Approved by the Guidelines Review Committee. Geneva; 2008.
  • 15. Street RJ, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: why some patients are more involved than others. Med Care. 2005;43(10):960-9. [PubMed: 16166865].
  • 16. Levy BT, Hartz A, Woodworth G, Xu Y, Sinift S. Interventions to improving osteoporosis screening: an Iowa Research Network (IRENE) study. J Am Board Fam Med. 2009;22(4):360-7. doi: 10.3122/jabfm.2009.04.080071. [PubMed: 19587249].
  • 17. Sabate E. Adherence to long-term therapies: evidence for action. World Health Organization; 2003.
  • 18. Alami S, Hervouet L, Poiraudeau S, Briot K, Roux C. Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views. PLoS One. 2016;11(6). e0158365. doi: 10.1371/journal.pone.0158365. [PubMed: 27355576].
  • 19. Nayak S, Roberts MS, Greenspan SL. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med. 2011;155(11):751-61. doi: 10.7326/0003-4819-155-11-201112060-00007. [PubMed: 22147714].
  • 20. Jalili Z, Nakhaee N, Askari R, Sharifi V. Knowledge, attitude and preventive practice of women concerning osteoporosis. Iran J Pub Health. 2007;36(2):19-25. Persian.
  • 21. Keramat A, Patwardhan B, Larijani B, Chopra A, Mithal A, Chakravarty D, et al. The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord. 2008;9:28. doi: 10.1186/1471-2474-9-28. [PubMed: 18304358].
  • 22. Gozashti MH, Shahesmaeili A. Is opium addiction a risk factor for bone loss? Iran Red Crescent Med J. 2011:464-8. Persian.
  • 23. Jafari M, Nakhaee N, Goudarzi R, Zehtab N, Barouni M. Participation of the Women Covered by Family Physicians in Breast Cancer Screening Program in Kerman, Iran. Asian Pacific J Cancer Prevent. 2015;16(11):4555-61. Persian.
  • 24. Hamrick I, Cao Q, Agbafe-Mosley D, Cummings DM. Osteoporosis healthcare disparities in postmenopausal women. J Womens Health (Larchmt). 2012;21(12):1232-6. doi: 10.1089/jwh.2012.3812. [PubMed: 23140203].
  • 25. Gathirua-Mwangi WG, Monahan PO, Stump T, Rawl SM, Skinner CS, Champion VL. Mammography Adherence in African-American Women: Results of a Randomized Controlled Trial. Ann Behav Med. 2016;50(1):70-8. doi: 10.1007/s12160-015-9733-0. [PubMed: 26416127].
  • 26. Adonis L, Basu D, Luiz J. Predictors of adherence to screening guidelines for chronic diseases of lifestyle, cancers, and HIV in a health-insured population in South Africa. Glob Health Action. 2014;7:23807. doi: 10.3402/gha.v7.23807. [PubMed: 24647130].
  • 27. Barcenilla-Wong AL, Chen JS, March LM. Concern and risk perception: effects on osteoprotective behaviour. J Osteoporos. 2014;2014.
  • 28. U.S. Dept of Health and Human Services RMU. Bone health and osteoporosis: a report of the Surgeon General. 2004.
  • 29. Cheng N, Green ME. Osteoporosis screening for men: are family physicians following the guidelines? Can Fam Physician. 2008;54(8):1140-1. 1141 e1-5. [PubMed: 18697977].
  • 30. World Health Organization WHO. Cancer control: knowledge into action: WHO guide for effective programmes. World Health Organization; 2007.
  • 31. Mottaghi P. Osteoporosis in Men: A Neglected Problem. Iran Red Crescent Med J. 2010;12(1):79. Persian.
  • 32. LaVallee LA, Scott MA, Hulkower SD. Challenges in the Screening and Management of Osteoporosis. N C Med J. 2016;77(6):416-9. doi: 10.18043/ncm.77.6.416. [PubMed: 27864493].
  • 33. Nakhaee N, Divsalar K, Meimandi MS, Dabiri S. Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran. Subst Use Misuse. 2008;43(3-4):513-20. doi: 10.1080/10826080701772348. [PubMed: 18365947].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments